Lipoprotein lipase (LPL) is widely linked to lipid and lipoprotein metabolism, but its effects on
coronary artery disease (CAD) are not clearly elucidated. The aim of the present study was …

Background: In recent years, the lipoprotein lipase (LPL) polymorphism has been
extensively investigated as a potential risk factor for coronary artery disease (CAD) …

Aims: Many studies and researchers have reported on the genetic association between
lipoprotein lipase (LPL) gene polymorphisms and myocardial infarction (MI). The results …

Coronary heart disease (CHD) is a major health problem and a major cause of death in most
countries. Evidence has been presented that gene polymorphisms (Hin dIII, Pvu II and …

OBJECTIVES The purpose of this study was to test whether the Hin dIII (+) and Pvu II (−) or
(+) restriction enzyme–defined alleles are associated with angiographic coronary artery …

Lipoprotein lipase (LPL) is a key enzyme in lipoprotein metabolism and a major candidate
gene for coronary heart disease (CHD). The authors assessed associations between 7 LPL …

Abstract Background and Aim: Coronary artery disease (CAD) is one of the leading causes
of death and disability around the world. Interaction between genetic and environmental …

Lipoprotein lipase (LPL) plays a central role in lipoprotein metabolism by hydrolyzing the
core triglycerides (TGs) of circulating chylomicrons and very-low-density lipoprotein (VLDL) …

Hyperlipidemia is a major risk factor for coronary artery disease (CAD). Lipoprotein lipase
(LPL) is an important enzyme in lipoprotein metabolism. S447X polymorphism of the LPL …

Coronary heart disease is a complex disease reflecting the interaction of multiple genes with
the environment (eg diet, life style). Lipoprotein lipase (LPL) plays an important role in lipid …